Bristol-Myers Squibb
BMY
BMY
2,313 hedge funds and large institutions have $84.2B invested in Bristol-Myers Squibb in 2024 Q1 according to their latest regulatory filings, with 168 funds opening new positions, 929 increasing their positions, 961 reducing their positions, and 176 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,313
Holders Change
-33
Holders Change %
-1.41%
% of All Funds
33.53%
Holding in Top 10
20
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16.67%
% of All Funds
0.29%
New
168
Increased
929
Reduced
961
Closed
176
Calls
$1.56B
Puts
$1.23B
Net Calls
+$325M
Net Calls Change
-$170M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.6B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$656M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$433M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$351M |
| 5 |
BlackRock
New York
|
-$301M |